Research study Program year 2022 Source: CMS Open Payments

Ph 3 Open-label Extension Study

Research payments

$3,925,509

223 payments

Through program year 2022, $3,925,509 in research payments was reported against Ph 3 Open-label Extension Study, across 223 payments, paid by Allergan Inc..

Paid by: Allergan Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$322,709	18
2021	Research	$3,602,800	205

Breakdown

Who paid Research payments · program years 2021–2022

Allergan Inc. $3,925,509 223 payments

Who received the money Research payments · program years 2021–2022

Eye Research Foundation INC Organisation paid for research $527,290 12 payments
Aventiv Research Organisation paid for research $453,478 13 payments
Advanced Research Associates Organisation paid for research $411,481 13 payments
A Professional Medical Corporation William P Coleman III MD Organisation paid for research $389,241 13 payments
Etre Cosmetic Dermatology And Laser Center Organisation paid for research $306,006 12 payments
M3 Wake Research INC Organisation paid for research $304,683 11 payments
Skin Search Of Rochester Inc Organisation paid for research $247,899 13 payments
Westlake Dermatology Organisation paid for research $230,193 12 payments
Virginia Clinical Research INC Organisation paid for research $193,552 12 payments
Investigate MD LLC Organisation paid for research $178,906 12 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.